Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Ceftriaxone PK in Meningitis
NCT01745679Phase 4Completed
- Sponsor
- CHU de Nantes
- Start
- Dec 2012
- Primary completion
- Dec 2015
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of ceftriaxone in meningitis, Central nervous system infection, sponsored by CHU de Nantes. Started Dec 2012; status: completed.
02
Drugs
ceftriaxone
03
Conditions
meningitisCentral nervous system infection
Beyond the preview
Go deeper on NCT01745679.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01745679.